MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.

Zhu, Lin; Liu, Xianhui; Zhang, Weiyu; Hu, Hao; Wang, Qi; Xu, Kexin

Zhu, Lin; Liu, Xianhui; Zhang, Weiyu; Hu, Hao; Wang, Qi; Xu, Kexin.

Afiliação

Zhu L; Department of Urology, Peking University People's Hospital, 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Liu X; Department of Urology, Peking University People's Hospital, 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Zhang W; Department of Urology, Peking University People's Hospital, 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Hu H; Peking University Applied Lithotripsy Institute, Peking University People's Hospital, Beijing, 100034, China.
Wang Q; Department of Urology, Peking University People's Hospital, 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Xu K; Department of Urology, Peking University People's Hospital, 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.

BMC Cancer ; 22(1): 556, 2022 May 17.

Article em En | MEDLINE | ID: mdl-35581573

Assuntos

Carcinoma de Células de Transição; Neoplasias da Bexiga Urinária; Antígenos B7; Carcinoma de Células de Transição/genética; Humanos; Oncogenes; Prognóstico; Bexiga Urinária

Palavras-chave

Biomarker; Immune infiltrates; MTHFD2; Prognosis; The Cancer Genome Atlas website; Urothelial carcinomas of bladder

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google